Overview

A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE)

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This study is for Type I or Type II diabetic subjects with with a diabetic foot ulcer. The study is being done to determine if Nexagon® plus standard of care is more effective than placebo plus standard of care. Standard of care will include debridement of the ulcer, standardized dressings and standardized off-loading using a Removable Cast Walker.
Phase:
Phase 2
Details
Lead Sponsor:
CoDa Therapeutics Inc.
OcuNexus Therapeutics, Inc.